Drug intelligence / Profile preview

FMT Capsule DE

Development stage: Unknown
Lead developer: University of Wisconsin-Madison
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

FMT Capsule DE is an investigational oral fecal microbiota transplantation (FMT) therapy developed by the University of Wisconsin, Madison. It consists of capsules containing processed fecal microbiota from healthy donors, intended to restore gut microbial diversity and provide colonization resistance. The drug is specifically being evaluated for the decolonization of multi-drug resistant organisms (MDROs), including Vancomycin-resistant Enterococcus (VRE) and Carbapenem-resistant Enterobacteriaceae (CRE), in the gastrointestinal tract. By re-establishing a healthy microbiome, FMT Capsule DE aims to prevent healthcare-associated infections and reduce the reservoir of antibiotic-resistant bacteria in colonized individuals.

Other names: Fecal Microbiota Transplantation CapsuleFMT capsules

Beyond the preview

Go deeper on FMT Capsule DE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FMT Capsule DE.

Explore the full profile